© Headspace Dorset 2014                                                       Tel:   077244 08383            Fax:  01202 366887              Mail:   info@headspacedorset.com        

                                              

77 Penn Hill Avenue, Poole, BH14 9LY                                    Registered with the Information Commissioner's Office - Registration Number ZA 028 421

OUR PURPOSE

We provide specialist out-patient assessment and treatment for people with anxiety, trauma and related mental health and substance misuse problems. We do not provide in-patient care, but can offer home-based care if circumstances demand. our aim is to to improve quality of life and help people with mental health difficulties re-integrate with their social and other networks, recover and achieve their aspirations.

 

Background 

 

Anxiety is common in the general population and in primary and secondary medical care. Symptoms may be mild and transient, but many people are troubled by severe and persistent symptoms that cause significant distress and impairment. When taken together Anxiety Disorders have a lifetime prevalence of approximately 21% with individual disorders are less frequent.

 

 

 

12-mo. prevalence

Lifetime prevalence

Any Anxiety Disorder

12%

15%

Panic Disorder

2.3%

3.8%

Specific phobia

7.6%

13.2%

Social phobia  

2.0%

5.8%

Generalised anxiety disorder (GAD)

1.5%

5.1%

Obsessive Compulsive Disorder (OCD)

0.7%

0.8%

Post-Traumatic Stress Disorder (PTSD)

1.2%

 

Source. British Association of Psychopharmacology Evidence-based Guidelines for the Treatment of Anxiety Dirsoders 2005

 

Anxiety disorders often co-occur or occur along with other mental health problems - commonly depression (approximately 33%) or substance abuse - which can make diagnosis and effective treatment more challenging. Where depression is co-morbid with an anxiety disorder it is generally indicative of greater severity and associated with poorer prognosis.

 

Primary care data studies suggests that improvement in approximately 50% of cases but complete recovery is relative rare, especially if symptoms are severe or long-standing. Long-term follow-up of participants in eight studies of cognitive behaviour therapy (CBT) for anxiety disorders found that 52% had at least one diagnosis at follow-up years later, with significant levels of co-morbidity and health scores comparable to the lowest 10% of the population. About 30% of cases returned for further treatment, continued to be prescribed medication and incurred high healthcare cost.

 

The short-term benefits of CBT do not appear prevent significant long-term co-morbidity and impairment in people with more than mild anxiety disorders. The National Institute for Health and Clinical Excellence (NICE) recommends a range of psychological and pharmacological therapies for people anxiety disorders in a stepped care model with systems for review to detect and act on non-improvement to consider stepping up to more intensive treatments, stepping down to less intensive treatment where appropriate, and stepping out when an alternative treatment or no treatment becomes  appropriate.

 

Patients vary and anxiety and depression are not the only presenting issues. CBT is not effective for everyone and the patient choice agenda is also important here. The national IAPT model requires interpretation in local contexts alongside other service provision.